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The risk of AIDS-related mortality increased dramatically throughout the 1990s. This paper updates previous
work by Fortson (2011) to examine the impact of mortality risk on human capital investment during the
deadliest period of the pandemic. We combine Demographic Health Survey data from 30 countries, across 60
survey waves, to generate a sample of over 1,300,000 observations. Cohort-specific analysis using the updated
sample yields new evidence that the negative relationship between HIV prevalence and schooling steepened
as mortality risk increased. The reduction in schooling is largest for women, and along the extensive margin
of the schooling decision. The findings indicate that the decline in human capital investment associated
with the HIV/AIDS pandemic prior to the availability of treatment was larger in magnitude than previously
understood, but may be reversing rapidly as access to treatment is expanded.
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1 Introduction
Over the course of three decades, the HIV/AIDS pandemic has significantly changed life expectancy and
mortality risk on a global scale. Today, there are over 37 million people living with HIV, and roughly 1.7
million new people become infected every year.1 However, the burden of infection is not equally distributed
across countries. Sub-Saharan Africa accounts for 71 percent of the global infection rate, with prevalence
rates exceeding 20 percent in some southern regions of the continent (Global Burden of Disease Collaborative
Network, 2018). Mortality rates from HIV are highest for prime-age adults, making this pandemic uniquely
consequential for human capital accumulation, labor market productivity, and economic growth.
Using 2001 to 2006 survey data for fifteen Sub-Saharan African countries, Fortson (2011) identified
a negative relationship between HIV prevalence and human capital investment. This effect was found to
primarily operate through an individual’s expectation of a shorter life span, leaving fewer years to accumulate
returns to human capital, and disincentivizing investment in schooling. Due to the increased salience of the
mortality risk generated by the HIV/AIDS pandemic for post-1990 cohorts – the youngest fully captured
birth cohort in Fortson (2011) – we investigate whether the effect of HIV on schooling changed for individuals
born in the following decade. We use data from 2001 to 2017 Demographic and Health Surveys (DHS) for
a sample of 30 Sub-Saharan Africa countries, and construct region definitions with consistent boundaries
across time.
We find that the HIV pandemic has reduced educational attainment, and that the relationship between
HIV prevalence and schooling became increasingly negative as mortality risk increased. The evidence is
consistent with the economic theory that investment in schooling is curtailed in response reductions in life
expectancy. A number of alternative explanations are ruled out; for example, there is no evidence that
the results are driven by decisions to forfeit schooling to care for HIV-positive family members, nor due to
increases in orphanhood. In contrast to Fortson (2011), we find that HIV has a larger effect on women’s
schooling, which is most associated with reductions on the extensive margin decision to enter school. Finally,
we introduce evidence that the negative effect on the school entry decision has begun to move back towards
zero for cohorts entering school following the rapid expansion of antiretroviral therapy (ART).
The difference in disease environment for the newly added cohorts is described in Figure 1 using time
trends for HIV prevalence and AIDS related mortality counts at age six – the age at which the initial
schooling decision is made. The expanded sample used throughout the paper includes the 1991 to 2000
cohorts, a period during which prevalence in Sub-Saharan Africa peaked and AIDS-related death counts
continued to rise in the region. The early schooling decisions for these cohorts were being made prior to the
1Data are for the year 2018, and can be found at http://aidsinfo.unaids.org.
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large expansion in access to treatment. The central analysis in this paper investigates whether investments
in human capital evolved as the mortality risk of the disease continued to intensify. Supplementary analysis
extends the sample to include children as young as seven years old and cohorts entering school after the peak
in AIDS-related mortality.
The formal theory of the relationship between life expectancy and human capital investment was laid out
in Jayachandran and Lleras-Muney (2009), and the negative relationship is shown to empirically exist in Sri
Lanka, a setting entirely independent from the one studied here. Godlonton and Thornton (2013) and Gong
(2014) have documented that updated information regarding the severity of HIV/AIDS risk or HIV status
can lead to changes in behavior. However, as adult access to ART continues to expand and life expectancy
losses are reversed (Bor et al., 2013), increases in expected longevity is a channel that may motivate parents
to reinvest in the education of their children (Baranov and Kohler, 2018; Lucas et al., 2019), their child’s
health (Lucas and Wilson, 2013), increase savings (Baranov and Kohler, 2018), and enter the labor market
(Baranov et al., 2015). The expansion of ART has also been found to explain a significant portion of recent
increases in economic growth throughout Africa (Tompsett, 2020).
The findings in this paper suggest that the previous work examining HIV/AIDS related mortality and
human capital investment was too early to capture the evolution of the relationship as the pandemic peaked
and has now begun to retreat. Furthermore, the greatest reductions in schooling are found in the earliest
grades and for women, this introduces the question of whether the pandemic has contributed to broader
inequality in schooling attainment.
2 Data and Empirical Methodology
2.1 Data
Fortson (2011) used household survey data from 2001 to 2006 DHS for 157 regions in 15 Sub-Saharan African
countries, and the corresponding HIV-test result data to assign regional HIV prevalence rates. Shown
in the following section, our narrow replication of Fortson (2011) uses her exact data and specifications,
and our slightly modified replication makes two changes: (i) population weights are adjusted using World
Development Indicators (World Bank, 2020) population estimates for the survey years, instead of 2007
population counts for all survey waves, and (ii) pre-1965 cohorts are excluded to maintain a consistent
sample when analyzing cohort specific effects while ensuring a sufficient number of observations in each
cohort. Following successful replication, we expand on Fortson (2011)’s findings in a number of ways. First,
we include updated survey waves from 2007 to 2017 for the original countries to account for the progression of
HIV infection across an additional decade.2 Second, 15 additional countries are included using survey waves
2In addition to the original survey waves from Fortson (2011), the updated survey years for the original fifteen countries
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from 2007 to 2016.3 Each survey wave includes an HIV-testing module that is used to calculate regional
prevalence rates. In each sample, regions are redefined to be consistent across survey rounds; therefore, when
the sample of countries is held constant, but the range of survey years is increased, the number of observed
boundary consistent regions is reduced to accommodate changes in region definitions between survey rounds.4
Table 1 provides summary statistics of individual characteristics for children and adults using the sample
of all 30 countries. In the adult sample, the average regional HIV prevalence rate is 5.3 percent, with a
standard deviation of 6.4; the children sample yields similar information with an average of 4.7 and standard
deviation of 5.8. A summary of regional HIV prevalence rates by survey year for the thirty countries in
our sample is provided in Appendix Table A.1. A change of 6.4 percentage points, the standard deviation
in the adult sample, is similar to a change in the prevalence rate from Rwanda (2014) to Malawi (2015).
Prevalence rates vary considerably across and within countries, and over survey years. Over the last two
decades, a number of countries have been making considerable progress in reducing prevalence rates (e.g.
Malawi, Zambia, Zimbabwe), while other have stagnated or continued to see rates increase (e.g. Côte d’Ivoire,
Lesotho, Mozambique). Nationally, the highest HIV prevalence rate in the sample is 24.17 percent in Lesotho
in 2014, and the lowest is 0.33 in Niger in 2012.
For adults, we measure education attainment using years of schooling, and two indicator variables for
whether the individual completed any school (at least one year), and if they completed their primary school
education. As shown in Table 1, adults in the sample completed an average of 5.7 years of schooling, 74
percent have completed at least one year, and 48 percent completed primary school. Educational attainment
information is also included for children; however, due to their age, schooling is likely to be incomplete.
Therefore, we also measure children’s progression through school by calculating the number of years children
are behind the appropriate grade for their age. In this sample, children are an average of 2.2 years behind
grade for age.
Finally, we construct cohort-specific estimates of regional HIV prevalence rates for the time period cov-
ering the initial outbreak of the disease through 2016. This cohort-specific measure is constructed using
annual country-level estimates from the Global Burden of Disease (GBD) Study (Global Burden of Disease
Collaborative Network, 2018; Murray et al., 2018; Roth et al., 2018) and combined with relative DHS preva-
lence rates in regions across each country, from each survey wave. For example, the prevalence rate in the
include, Burkina Faso (2010), Cameroon (2011), Cote d’Ivoire (2011), Ethiopia (2011, 2016), Ghana (2008, 2014), Guinea
(2012), Kenya (2008, 2012), Lesotho (2009, 2014), Malawi (2010, 2015), Mali (2006, 2012), Niger (2012), Rwanda (2010, 2014),
Senegal (2010, 2014), Tanzania (2007, 2011), and Zambia (2007, 2013).
3The new countries and survey years include Angola (2015), Burundi (2010, 2016), Chad (2014), Congo (2005, 2009, 2011),
Democratic Republic of Congo (2007, 2013), Gabon (2012), Gambia (2013), Liberia (2007, 2013), Mozambique (2009, 2015),
Namibia (2006, 2013), Sierra Leone (2008, 2013), South Africa (2016), Togo (2013), Uganda (2006, 2011, 2016), and Zimbabwe
(2005, 2010, 2015).
4Boundary consistent region definitions are taken from IPUMS-DHS when possible, and supplemented when necessary using
shapefiles available at the DHS Program’s Spatial Data Repository and information from statoids.com.
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northern region of Malawi was 68 percent of the national prevalence in the 2004 wave of the DHS (8.04
relative to 11.79); therefore, the northern region is assigned 68 percent of the GBD’s national estimate in
2004 (10.5 versus 15.4). For non-survey years, national prevalence is estimated assuming a linear trend in
regional prevalence between survey years. For all years prior to the first DHS survey (and after the most
recent wave), the dispersion across regions is assumed to be constant, and equal to the relative prevalence
in the initial (final) survey. When these data are used in analysis, observations from each birth cohort are
matched with the prevalence rate in their region during their age six year. This is to simulate the mortality
risk environment in which they, or their family, make their initial schooling decisions. Using an annual esti-
mate allows us to both expand the sample to include DHS household survey data from the 1990s to account
for the effect of HIV prevalence on human capital investment over an additional decade, and to introduce
variation in the prevalence rate across cohorts.
2.2 Empirical Methodology
Fortson (2011) used a difference-in-differences (DiD) method comparing educational outcomes of pre- and
post-1980 cohorts across regions with varying HIV prevalence rates. Educational outcomes (i.e. years of
schooling, any schooling, and primary school completion) were regressed on HIV prevalence in the survey
year, interacted with an indicator for the post-1980 cohort. The schooling decisions for the first post-1980
cohorts were made based on prevalence information from the late 1980s and early 1990s, largely before the
scale of the mortality risk was fully understood.5 In both the replication, and when using the expanded
sample, we largely follow the same estimation equation:
Siycr = β0 + β1HIVyr × ✶ [c ≥ 1980] + β2Femaleiycr + β3Ruraliycr
+θg (ageiycr) + γc + αry + εiycr.
(1)
Siycr is an educational outcome for respondent i, observed in year y, in birth cohort c, and region r. Initial
replication estimates include only a single survey for each country. In this case, the main explanatory variable
interacts regional HIV prevalence from the only available survey year, HIVr, and an indicator for being born
in or after 1980, ✶ [c ≥ 1980]. The coefficient on this variable, β1, is the estimated effect of an additional
percentage point of HIV prevalence on the human capital measure, Siycr, for the post-1980 cohorts relative
to individuals born before the cutoff. There are two additional indicators, one for whether the individual is
female, and one for living in a rural area; γc is a fixed effect for birth cohort. In samples without multiple
survey rounds for each country, αr is a fixed effect for region r; when the sample is expanded, we substitute
5The first rapid HIV test was not approved by the U.S. Food and Drug Administration (FDA) until in 1992; the current
definition of progression to AIDS, a CD4 count below 200, was only established U.S. Center for Disease Control in 1993 (Kaiser
Family Foundation); UNAIDS came into existence in 1996 (avert.org).
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a vector of region-by-year fixed effects (αry) and a cubic control for age. Finally, because the ideal data
would have cohort specific measures of prevalence, instead of variation in the year of survey, an additional
specification substitutes the cohort- and region-specific GBD estimates described in the previous section for
the interaction term in equation (1). In all specifications, standard errors are clustered at the region level
to allow for arbitrary within region correlation in the error term (Bertrand et al., 2004).
The model described in equation (1) assumes that there is a change in the relationship between schooling
and future HIV prevalence for individuals born after 1980. To investigate this assumption, we allow the
model to estimate the relationship between a time-invariant prevalence measure (HIV maxr ) and schooling
for each cohort, where HIV maxr is the maximum observed prevalence rate in each region across DHS survey
rounds. The set of cohort-specific estimates are generated using the following model:






βb✶ [c = b] +
2000∑
b=1980
βb✶ [c = b]
]
+β2Femaleiycr + β3Ruraliycr + θg (ageiycr) + γc + αry + εiycr.
(2)
The outcome variable, Siycr, is the same as the previous equation. HIV
max
r is the HIV prevalence measure
in each region r. ✶ [c = b] is an indicator equal to one when individual i is born in year c. The 1979 cohort,
defined as the final pre-1980 cohort in Fortson (2011), is left to be the reference group. All other variables are
the same as equation (1). The coefficient, βb, is the cohort specific effect of an additional percentage point
of HIV prevalence, relative to the omitted cohort. If the underlying assumptions of the DiD model described
in equation (1) are valid, these estimates should not be different from zero prior to the 1980 cohort.
3 Results
3.1 Baseline Difference-in-Differences Estimates
The results of the replication of Fortson (2011)’s central model are shown in column (1) of each panel in
Table 2. All results in Table 2 use a sample of adults from 15 to 49 years old who were born in or after
1965. Our estimates for the effect of HIV prevalence on attending any school, column (1) in Panel B, and
completing primary school, Panel C, are almost identical to the original findings, while our estimate for the
effect of HIV on years of schooling is slightly larger (-0.067 compared to -0.053 in Fortson, 2011).6
In Table 2, column (2) of each panel includes new survey waves for the fifteen original countries, adding
data from 2006–2017. In this specification, we use a regional HIV prevalence measure specific to both
region and survey year, include a cubic polynomial for age, and reduce the number of regions to 131 to
6We are also able to directly replicate Fortson (2011)’s exact model, and match within 0.001 of her estimated coefficient on
the interaction term. The output comparing the original model to the alternations in our preferred specifications can be found
in Appendix Table A.2. The only differences between column (1) of Table 2 and Fortson (2011)’s Table 4 are the use of survey
year specific populations to scale sample weights, instead of 2007 populations for all survey years, and restricting the sample
to the post-1965 set of cohorts.
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maintain regional boundaries consistent throughout the extended time period. In the updated sample, a one
percentage point increase in HIV prevalence decreases educational attainment by 0.06 years, the likelihood
of attending any school by 0.9 percentage points, and the completion of primary school by 0.5 percentage
points.
The remaining columns in Table 2 expand the sample of countries to include a total of 30 countries,
and 289 regions, using survey waves from 2001-2017. Findings for the effect of HIV prevalence on years of
schooling with two different definitions of regional fixed effects are shown in columns (3) and (4). Adding the
region by survey year fixed effects in column (4) yields nearly identical results. Notably, when the sample
is expanded to 30 countries, the relationship between HIV prevalence and the completion of primary school,
shown in Panel C of Table 2, is no longer statistically significant. The effect on primary school completion
may be less robust than previously understood, suggesting a more prominent relationship between HIV
and dropout in the early years of primary school, and specifically, the extensive margin of the school entry
decision.7
The results in the first four columns of Table 2 use prevalence rates associated with the year each adult
is observed. To ensure these findings are not attributable to variation in HIV prevalence across the survey
waves of each country, we use the highest regional HIV prevalence rate across the survey waves as our HIV
measure. When doing so, the magnitude and statistical significance remain consistent for all education
outcomes, shown in column (5). In fact, although smaller in magnitude, the result for primary school
completion is again statistically significant.
To this point, the measures of HIV prevalence from DHS modules are likely accurate but may not reflect
the distribution of perceived mortality risk at the time of each individual’s schooling decision. To address this
issue, we introduce a cohort-specific estimate of regional HIV prevalence that assigns prevalence at age six
to each observation, which we consider to be roughly the age at which the initial human capital investment
decision for children is made. Although a number of assumptions are needed to create these cohort-specific
regional prevalence estimates, this method concedes some accuracy to approximate the ideal dataset of cohort
specific mortality risk. Furthermore, the cohort-specific measures allow us to expand the sample to DHS
waves without attached HIV data; 45 additional DHS waves without an attached HIV module – largely from
the 1990s – are included in the sample. The results for this expanded sample and cohort-specific measure,
reported in column (6), remain largely unchanged. A one-percentage point increase in age six HIV prevalence
is associated with a decrease of 0.039 years of schooling and a 0.6 percentage point decrease in the likelihood
of attending any school. The coefficient on primary completion is again statistically significant but smaller
7Further evidence that the declines in schooling are concentrated among those dropping out of the earliest years is shown in
Appendix Table A.4. The reduced likelihood of grade completion is largest for grade one and remains negative and statistically
significant through at least grade five, but the magnitude of the effect becomes more muted at each successive level.
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in magnitude than the original estimates.
From these results, we can confirm the negative effect of HIV prevalence on human capital investment
originally found in Fortson (2011) for a larger sample of countries, with over two decades of HIV prevalence
rate data. In our fully extended sample with most flexible controls, column (4), we find that a one percentage
point increase in HIV prevalence is associated with a reduction in schooling of 0.033 years, and a decreased
likelihood of ever attending school of 0.7 percentage points. Evidence of reductions in schooling in the early
years of primary school suggests that the HIV/AIDS pandemic may be further amplifying the inequality in
human capital investment between those who see significant returns from large investments, and marginal
students for whom small reductions in expected returns make any schooling investment suboptimal.
3.2 Cohort Specific Effect of HIV Prevalence
The expanded sample allows for a more detailed cohort-specific analysis. Equation (2) is used to estimate
a set of cohort-specific effects from 1965 to 2000, with the 1979 cohort set as the omitted group. The
magnitude of these estimates and their confidence intervals are shown in Figure 2. For all three outcomes,
prior to 1980, there is no persistent relationship between the future maximum HIV prevalence rate and
the education outcome being examined. This finding reinforces the DiD assumption necessary to estimate
equation (1), that future HIV prevalence rates are not correlated with schooling decisions for cohorts born
prior to 1980.8
The results in Panels A and B of Figure 2 demonstrate that HIV has a progressively more negative
effect on years of schooling and attending any school for younger cohorts. For each outcome in the first two
panels, the estimated effect is negative and statistically significant beginning with the 1987 cohort, and then
continues to increase in magnitude. In both cases, the estimated effect for the final cohort in the sample is
more than twice as large as the average effect shown in Table 2. It is important to note that the schooling
entry decision for the entire set of cohorts is largely made prior to the expansion of access to treatment;
this extensive margin decision impacts a relatively large portion of the population, and changes in years of
schooling moves along a similar pattern.
As seen in Panel C of Figure 2, the effect on primary completion is negative over the same range of
cohorts. However, the decline does not become progressively more negative for later cohorts in the sample.
The final decision to complete primary school is being made six to eight years after the school entry decision.
For these cohorts, these decisions are more likely to be impacted by the availability of ART and increases
in life expectancy that accompany the treatment. While certainly not conclusive, the findings in Panel C of
8A replication of the placebo test performed in Fortson (2011)’s Table 6 is included in Appendix Table A.3. Although there
are some small negative estimates for the relationship between any schooling and prevalence, Panel B of Figure 2 yields more
detailed evidence of a lack of a pre-1980 relationship, one that consistently hovers around zero for cohorts in the 1970s, and
through 1986.
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Figure 2 behave in a pattern consistent with an initial decline in life expectancy that is then halted if not
reversed as the benefits of treatment are beginning to be realized.
In addition to the trends seen in Figure 2, since there is not a relationship between HIV and human
capital investment for pre-1987 cohorts, the DiD estimate defining 1980 as the point when treatment is
introduced seems to include a number of “pre-treatment” cohorts in the post-treatment period. This likely
leads to an underestimate of the true effect, assuming that the understanding of the risk changed closer to
1987, as suggested by Figure 2. Re-estimating the DiD model, equation (1), using 1987 as the cutoff cohort
behaves as expected, yielding larger estimated effects for all three outcomes, each statistically significant at
the 99 percent confidence level. For example, the estimated effect on years of schooling increases from 0.046
in the original specification to 0.089 in the 1987 specification.9
3.3 Exploring Alternative Channels of Effect
The strong negative relationship between HIV prevalence and human capital investment is consistent with
the human capital model described in Fortson (2011). However, in addition to mortality risk, there are
several other mechanisms through which HIV prevalence can affect education outcomes. A number of these
alternative mechanisms are explored here.
Orphanhood and caretaking requirements. Orphans are less likely to attend school than nonor-
phans (Evans and Miguel, 2007; Haacker, 2016); therefore, if high-HIV areas have a disproportionate number
of orphans, it could explain the strong negative relationship between HIV prevalence and human capital in-
vestment. Another explanation is caretaking requirements, which could reduce time spent in school for
children that live in households with HIV-positive adults. To test these pathways we measure human capital
investment using years behind in school for age using a sample of children aged 7 to 14. From the data, we
know whether the parents of these children are alive, and within the HIV-testing sample, the HIV status of
the adults within their household. This replicates Table 8 in Fortson (2011).
The DiD model described by equation (1) is again used here; following Fortson (2011), the 1992 cohort
is used as the treatment threshold. For this sample, HIV prevalence – defined by region and survey year
– is ideally recorded at the time of the decision regarding the child’s schooling. The results are shown in
Table 3.10 The effect of HIV prevalence on the prescribed progression through school is shown in column (1)
for all children, and in column (2) for all nonorphan children (defined as having both a living mother and
father). For both samples, HIV prevalence slows the progression through school to a similar degree, indicating
that orphanhood is not a pathway through which HIV prevalence impacts human capital investment. The
caretaking requirement pathway is tested in columns (3) and (4). The sample in column (3) includes only
9These estimates can be found in Appendix Table A.5.
10Estimates directly replicating Table 8 in Fortson (2011) can be found in Appendix Table A.6.
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children whose household was selected for the HIV testing module, and column (4) restricts the sample to
children who live in households with no HIV-positive members. Given that HIV prevalence has an almost
equal effect on children with no caretaking requirements, an increased need for caretaking cannot explain
the negative effect of HIV prevalence on schooling.
Migration and Differential Mortality. Due to migration, individuals observed as adults may have
faced a significantly different HIV environment when their education decisions were made. By using children
aged 7-14 in our analysis, we are able to avoid this concern. In this analysis, we remove the measurement
error introduced when observing post-migration adults by matching regional prevalence data to individuals
at the age when their schooling decision is made. The findings from Appendix Table 3 demonstrate that
the negative relationship between HIV and schooling exists prior to the possibility of any adult migration
decision.
Alternatively, if HIV prevalence is highest among those who are highly educated (Fortson, 2008) then
the association between HIV prevalence and lower levels of schooling could be biased a survivor bias. To
investigate this the analysis from Fortson (2011)’s Table 7 is repeated and the sample is restricted to those
between the ages of 15 and 25. The mortality rate of this age range is less than one-fifth of the 25 to 49
age range (IHME, 2015). The estimates for the paper’s three main schooling outcomes are negative and
statistically significant, and are shown in Appendix Table A.7. These findings, along with the negative effect
on schooling for the children aged 7-14, demonstrate that the results exist for samples not greatly affected
by the high rates of mortality. These two sets of findings suggest that the relationship between HIV and
education outcomes is not driven by migration and differential mortality.
Child Labor. Heightened levels of prime-aged adult mortality could be leading to shortages in labor
supply which would generate an upward pressure on wages. It is possible that children are leaving school
to fill these higher paying vacancies. To examine this possibility Fortson (2011)’s model for children aged 7
to 14 is again estimated, using data from the 20 (of 60) survey waves with a child labor module.11 For this
sample, we find no evidence that higher rates of HIV prevalence are associated with an increased likelihood
of working for pay for non-family members, or working in any type of family enterprise. We then show that
higher rates of HIV prevalence continue to be associated with falling further behind in school, for both the
full sample of children from these 20 surveys and after dropping all children reported to be engaging in either
type of work. These results demonstrate that the negative impact on schooling persists even for children not
attracted to the labor market due to potentially higher wage rates.
11These results are shown in Appendix Table A.8.
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3.4 Differences between Men and Women
We might expect HIV prevalence to affect human capital investment for men and women differently due to
differences in the timing of HIV mortality rates, generally affecting women at younger ages.12 Figure 3 shows
the effect of regional HIV prevalence on years of school completed for men (Panel A) and women (Panel B)
born from 1965 to 2000. The decline seems to begin slightly earlier for men; however, the first statistically
significant negative result is estimated in 1987 for women and 1988 for men. The pronounced decline in
women’s schooling is driven by a significantly larger decline in the school entry decision. This suggests the
possibility that, on average, the decision to send women to school may be more marginal. In all cases, the
effect on men’s schooling investment does not continue to decline for the later cohorts; in fact, the effect for
men’s primary completion moves back towards zero for the latest cohorts in the sample.13
The findings seen in Figure 3 are the opposite of the those in Table 9 of Fortson (2011).14 However,
the key conclusion taken from these results holds, differences in the evolution of the effect on educational
outcomes between the sexes suggests that HIV prevalence is not affecting human capital investment through
a third possible channel of schooling provision. If educational attainment was falling due to a reduction in
supply, possibly caused by fewer available teachers, the pattern of the effect across cohorts would likely be
similar for both men and women. However, the decline in years of schooling for women begins slightly later
and all outcomes show evidence of a steadily increasingly negative effect. Alternatively, the effect on men’s
schooling seems to plateau for the later cohorts.
3.5 Expansion of ART and Completing Any School
Antiretroviral therapy is able to substantially increase life expectancy (Bor et al., 2013), and since 2000,
access to this treatment has rapidly expanded. As late as 2003 less than 1% of the HIV positive population
in the 30 countries examined here had access to treatment (World Bank, 2020). By 2009 – the year the first
students from the 2002 cohort completed grade one – more than 18% of the HIV positive population had
access to ART, and in 2015 more than 50% of the relevant population were being treated.
If the decline in schooling is driven by increased mortality risk generated by HIV/AIDS, the expansion of
treatment should reduce the effect once the improvement in life expectancy is incorporated into the decision-
making process. However, the most recent survey used in the study is from 2017; those who are 15 years
12In 2005, HIV/AIDS mortality rates were twice as high for women between the ages of 20 and 24, 40% higher between the
ages of 25 and 29, and 13% higher between the ages of 30 and 34 (IHME, 2015). Cohort specific estimates of AIDS-caused
mortality rates for South Africa yield a similar finding (Chicoine, 2012).
13The charts with grade one and primary completion for both men and women can be found in Appendix Figure A.1.
14There are three key explanations for the divergence of the sex-specific results from Fortson (2011). These are explored in
Appendix Table A.9. First, the original model was not a fully specified triple difference model, once the missing interaction
terms are added the effect of HIV prevalence on women’s schooling becomes negative – column (2). Second, the data from the
fifteen new countries removes any evidence that the effect for men differs – column (4). Finally, the cohort-specific estimates
uncover dynamics across time that are not visible when assuming treatment occurs at a single point in time.
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old in this survey wave were born in 2002, prior to a majority of the expansion of ART. Therefore, to study
the period of ART expansion younger ages have to be included in the sample. To do this, we expand the
sample to include ages from 7 to 49 and focus on the any schooling outcome. Although there are a number
of children between the ages of 7 and 15 who have not yet attended school but will do so in the future, this
outcome provides the best comparison across these ages and an initial understanding of whether the trend
we have seen through the 2000 cohort using the baseline sample persists for these younger cohorts.
To conduct this analysis, equation (2) is estimated for the expanded sample; the output is shown in
Figure 4. The pattern is nearly identical to Panel B of Figure 2 through the 1997 cohort. After 1997, the
decline is less steep over the next four cohorts, before beginning to move back towards zero for those born
in 2002. In fact, by 2008 the effect is no longer statistically significant and is less than 30% the size of the
effect for the 2001 cohort – the largest estimate in the sample. While there is certainly more work to be
done to definitively link these findings to local measures of mortality risk, this evidence is consistent with
the theory that increased mortality risk generated by the HIV/AIDS pandemic led to significant declines in
human capital investment.15
4 Conclusion
Consistent with Fortson (2011), we find a strong negative relationship between HIV prevalence and human
capital investment. The effect of HIV on educational attainment is consistent with economic theory –
an expectation of a shorter lifespan can lead to reduced investments in schooling. We find no evidence
that orphanhood, caretaking requirements, migration patterns, survivor bias, increases in child labor, or
the provision of schooling are able to explain the relationship between HIV and reduced human capital
investment found throughout the paper.
Importantly, our findings provide evidence that the consequences of the HIV/AIDS pandemic for schooling
may be greater than previously documented. The larger effects on the extensive margin suggest that the
increased mortality risk may be driving students at the margin of attending school out of the classroom
earlier. Students are completing fewer year of school and are less likely to attend any school as the risk of
future mortality increases. In the aggregate, this effect may be widening the gap in educational attainment
between students with high expected returns and those on the margin of attendance. The expanded inequality
has the potential to amplify over time, as it has been shown that worsened economic conditions, in this case
possibly generated by lower levels of schooling, can lead to higher rates of HIV (Burke et al., 2014), and
higher rates of HIV have also been shown to feed back to lower wages and employment rates (Chicoine, 2012;
15Additional estimates of the effect of HIV prevalence on the likelihood of completing at least grade one using the expanded
sample can be found in the appendix. In Appendix Figure A.1, for men (Panel E) and women (Panel F); and in Appendix
Figure A.3, for urban (Panel A) and rural (Panel B) households.
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Levinsohn et al., 2013).
The findings are consistent with increased access to AIDS treatment improving life expectancy and a
reducing in the impact of the disease on human capital investment. As more data on ART become available,
it will be important to further investigate how reductions in mortality, increases in life expectancy (Bor
et al., 2013), and changes in behavior (Thirumurthy and Graff Zivin, 2012; Baranov et al., 2015; Baranov and
Kohler, 2018; Friedman, 2018) can lead to updated expectations of longevity and further reverse the decline in
human capital investments found in this paper. Additionally, if socioeconomic status is positively correlated
with access to treatment, the treatments themselves could further compound inequalities in human capital
accumulation already magnified by the pandemic. Finally, future research aimed at better understanding
the differences in response by gender could play a vital role in uncovering the more detailed mechanisms of
how mortality risk associated with HIV/AIDS has altered the human capital investment decision.
12
References
Baranov V, Bennett D, Kohler HP. 2015. The Indirect Impact of Antiretroviral Therapy: Mortality Risk,
Mental Health, and HIV-negative Labor Supply. Journal of Health Economics 44: 195–211.
Baranov V, Kohler HP. 2018. The Impact of AIDS Treatment on Savings and Human Capital Investment
in Malawi. American Economic Journal: Applied Economics 10: 266–306.
Bertrand M, Duflo E, Mullainathan S. 2004. How Much Should We Trust Differences-In-Differences Esti-
mates? Quarterly Journal of Economics 119: 249–275.
Bor J, Herbst AJ, Newell ML, Bärnighausen T. 2013. Increases in Adult Life Expectancy in Rural South
Africa: Valuing the Scale-up of HIV Treatment. Science 339: 961–965.
Burke M, Gong E, Jones K. 2014. Income Shocks and HIV in Africa. Economic Journal 125: 1157–1189.
Chicoine L. 2012. AIDS Mortality and Its Effect on the Labor Market: Evidence from South Africa. Journal
of Development Economics 98: 256–269.
Evans DK, Miguel E. 2007. Orphans and Schooling in Africa: A Longitudinal Analysis. Demography 44:
35–57.
Fortson JG. 2008. The Gradient in Sub-Saharan Africa: Socioeconomic Status and HIV/AIDS. Demography
45: 303–322.
Fortson JG. 2011. Mortality Risk and Human Capital Investment: The Impact of HIV/AIDS in Sub-Saharan
Africa. Review of Economics and Statistics 93: 1–15.
Friedman WH. 2018. Antiretroviral Drug Access and Behavior Change. Journal of Development Economics
135: 392–411.
Global Burden of Disease Collaborative Network. 2018. Global Burden of Disease Study 2017 (GBD 2017)
Covariates 1980-2017. University of Washington: Institute for Health Metrics and Evaluation (IHME).
Godlonton S, Thornton RL. 2013. Learning from Others’ HIV Testing: Updating Beliefs and Responding to
Risk. American Economic Review 103: 439–44.
Gong E. 2014. HIV Testing and Risky Sexual Behaviour. Economic Journal 125: 32–60.
Haacker M. 2016. The Economics of the Global Response to HIV/AIDS. Oxford University Press.
Institute for Health Metrics and Evaluation (IHME). 2015. HIV Worldwide 1990-2013. Seattle, WA: IHME,
University of Washington. Available from http://vizhub.healthdata.org/hiv (Accessed 2/11/20).
Jayachandran S, Lleras-Muney A. 2009. Life Expectancy and Human Capital Investments: Evidence from
Maternal Mortality Declines. Quarterly Journal of Economics 124: 349–397.
Levinsohn J, McLaren ZM, Shisana O, Zuma K. 2013. HIV Status and Labor Market Participation in South
Africa. Review of Economics and Statistics 95: 98–108.
Lucas AM, Chidothe M, Wilson NL. 2019. Effects of Adult Health Interventions at Scale on Children’s
Schooling: Evidence from Antiretroviral Therapy in Zambia. Economics of Education Review 72: 107–
120.
Lucas AM, Wilson NL. 2013. Adult Antiretroviral Therapy and Child Health: Evidence from Scale-up in
Zambia. American Economic Review 103: 456–61.
Murray CJ, Callender CS, Kulikoff XR, Srinivasan V, Abate D, Abate KH, Abay SM, Abbasi N, Abbastabar
H, Abdela J, et al. 2018. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–
2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet 392: 1995–2051.
13
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela
J, Abdelalim A, et al. 2018. Global, Regional, and National Age-sex-specific Mortality for 282 Causes
of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of
Disease Study 2017. The Lancet 392: 1736–1788.
Thirumurthy H, Graff Zivin J. 2012. Health and Labor Supply in the Context of HIV/AIDS: The Long-run
Economic Impacts of Antiretroviral Therapy. Economic Development and Cultural Change 61: 73–96.
Tompsett A. 2020. The lazarus drug: The impact of antiretroviral therapy on economic growth. Journal of
Development Economics 143: 102409.
World Bank. 2020. World Development Indicators. Washington, D.C. Available from
http://wdi.worldbank.org (Accessed 2/11/20).
14
Figure 1: AIDS-related Deaths and HIV Prevalence at Age Six, by Birth Year
Note: Birth years are matched with statistics for the age six year of each cohort, approximately when the initial schooling decision is
made. Time trends represent HIV prevalence rates across the 30 country sample (Global Burden of Disease Collaborative Network,
2018) and count estimates of AIDS-related deaths (worldwide from avert.org; Sub-Saharan Africa from IHME, 2015).
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(a) Years of Schooling
(b) Any School (Years of School > 0)
(c) Completed Primary School
Figure 2: Effect of HIV Prevalence on Education Outcomes, by Birth Year
16
(a) Men (b) Women
Figure 3: Effect of HIV Prevalence on Years of School, by Birth Year: Differences by Sex
Figure 4: Effect of HIV Prevalence on Completing Any School (Years of Schooling > 0; Ages 7-49)
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Table 1: Summary Statistics: Individuals
Age 7−14 Age 15−49
N Mean s.d. N Mean s.d.
HIV Prevalence (region; survey year) 787,840 4.682 5.763 1,329,306 5.331 6.407
Years of schooling 784,438 2.179 2.167 1,320,655 5.651 4.528
Any Schooling (Years of schooling > 0) 784,438 0.680 0.467 1,320,655 0.737 0.440
Completed primary school 785,173 0.058 0.234 1,323,191 0.479 0.500
Years behind grade for age 775,083 2.240 1.921 – – –
Year of birth 787,840 2000 4.933 1,329,306 1983 9.119
Female 787,821 0.493 0.500 1,329,304 0.530 0.499
Rural 787,840 0.750 0.433 1,329,306 0.650 0.477
Note: The sample includes individuals from DHS survey waves from 2001-2017 for the 30 countries described in footnotes 2
and 3. Each panel includes observations within the stated age range, and born in or after 1965.
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Table 2: Effect of HIV on Education Outcomes
A. Dependent Variable: Years of School
(1) (2) (3) (4) (5) (6)
Regional HIV Prevalencery -0.067*** -0.059*** -0.034*** -0.033***




Max. Regional HIV Prevalencer -0.033***
× Post-1980 Cohortc (0.011)
Regional HIV Prevalence at Age Sixrc
-0.039***
(0.015)
Regions 157 131 289 289 289 254
N 253,324 845,684 1,320,654 1,320,654 1,320,654 1,751,328
B. Dependent Variable: Any Schooling (Years of School > 0)
Regional HIV Prevalencery -0.006*** -0.009*** -0.007*** -0.007***




Max. Regional HIV Prevalencer -0.007***
× Post-1980 Cohortc (0.001)
Regional HIV Prevalence at Age Sixrc
-0.006***
(0.002)
Regions 157 131 289 289 289 254
N 253,324 845,684 1,320,654 1,320,654 1,320,654 1,751,328
C. Dependent Variable: Primary Completed
Regional HIV Prevalencery -0.009*** -0.005*** -0.001 -0.001




Max. Regional HIV Prevalencer -0.002**
× Post-1980 Cohortc (0.001)
Regional HIV Prevalence at Age Sixrc
-0.003**
(0.001)
Regions 157 131 289 289 289 254
N 253,513 846,325 1,323,189 1,323,189 1,323,189 1,754,126
Original countries Original countries; Expanded countries Expanded countries
Sample and survey waves expanded survey and survey waves and survey waves
(2001−2005) waves (2001−2017) (2001−2017) (1991−2017)
Age (cubic) X X X X X
Female indicator X X X X X X
Rural indicator X X X X X X
Birth year F.E. X X X X X X
Region F.E. X X X
Region × survey wave F.E. X X X
Note: The dependent variable is described at the top of each panel. In Panel A, it is years of schooling; an indicator for
completing any schooling in Panel B; and in Panel C, an indicator for completing primary school. The set of controls used in
each regression is detailed at the bottom of the table. Regional HIV prevalence is the regional prevalence rate in the survey
year in which each individual was observed. Max. regional HIV prevalence is a time-consistent measure of the highest recorded
prevalence rate in the region across all survey years, and regional HIV prevalence at age six is a cohort specific estimate of the
regional prevalence rate for each cohort’s age six year. All samples include adults between the ages of 15 and 49, born in or
after 1965. Standard errors are clustered by region and shown in parentheses.
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Table 3: Effect of HIV on Years Behind Grade for age: Ages 7 to 14
Full Sample No Orphans Testing Sample No HIV+ Member
(1) (2) (3) (4)
Regional HIV Prevalencery 0.076*** 0.079*** 0.075*** 0.075***
× Post-1992 Cohortc (0.010) (0.011) (0.014) (0.016)
Nonorphans in Nonorphans in HH with
Expanded countries Nonorphans; Expanded HIV testing sample; no HIV-positive individual;
Sample and survey waves countries and survey expanded countries expanded countries
(2001−2017) waves (2001−2017) and survey waves and survey waves
(2001−2017) (2001−2017)
Regions 289 289 289 289
N 775,064 653,798 367,377 332,555
Note: The dependent variable is years behind grade for age. Each regression includes a cubic for age, indicators for female and
living in a rural area, a set of birth year fixed effects, and region by survey wave fixed effects. Regional HIV prevalence is the
regional prevalence rate in the survey year in which each individual was observed. Nonorphan is defined as having both mother
and father alive; columns (3) and (4) include only households within the HIV testing sample. All samples include observations
between the ages of 7 and 14. Standard errors are clustered by region and shown in parentheses.
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Appendix (For Online Publication)
(a) Any School – Men (Ages 15-49) (b) Any School – Women (Ages 15-49)
(c) Completed Primary School – Men (Ages 15-49) (d) Completed Primary School – Women (Ages 15-49)
(e) Any School – Men (Ages 7-49) (f) Any School – Wiomen (Ages 7-49)
Figure A.1: Effect of HIV Prevalence on Education Outcomes by Birth Year: Differences by Sex
A.1
(a) Years of Schooling – Urban (b) Years of Schooling – Rural
(c) Any School – Urban (d) Any School – Rural
(e) Completed Primary School – Urban (f) Completed Primary School – Rural
Figure A.2: Effect of HIV Prevalence on Education Outcomes by Birth Year,
by Urban / Rural Status
A.2
(a) Any School (Ages 7-49); Urban Only
(b) Any School (Ages 7-49); Rural Only
Figure A.3: Effect of HIV Prevalence on Any School (Years of Schooling > 0; Ages 7-49)
by Urban / Rural Status
A.3
Table A.1: Regional HIV Prevalence, by Country and Survey Year
(1) (2) (3) (4) (5) (6)
Angola Burkina Faso Burundi Cameroon Chad Congo
Survey Year 2015 2003 2010 2010 2016 2004 2011 2014 2009
Mean 1.99 1.77 0.95 1.34 0.91 5.27 4.10 1.49 3.20
S.d. 1.20 1.09 0.56 0.74 0.51 2.67 2.10 1.19 1.17
Regions 18 13 13 4 4 12 12 21 12
(7) (8) (9) (10) (11)
DRC Côte d’Ivoire Ethiopia Gabon Gambia
Survey Year 2007 2013 2005 2011 2005 2010 2016 2012 2013
Mean 1.32 1.15 4.65 3.63 1.42 1.37 0.86 4.12 1.9
S.d. 0.78 0.89 1.24 1.00 0.97 0.95 0.68 0.99 0.6
Regions 11 11 10 10 11 11 11 10 8
(12) (13) (14) (15) (16)
Ghana Guinea Kenya Lesotho Liberia
Survey Year 2003 2014 2005 2012 2003 2008 2004 2009 2014 2007 2013
Mean 2.21 1.99 1.50 1.71 6.74 6.36 23.35 22.77 24.17 1.55 2.04
S.d. 0.90 0.81 0.55 0.57 4.14 3.88 3.67 2.83 3.38 0.85 1.18
Regions 10 10 5 5 8 8 10 10 10 5 5
(17) (18) (19) (20) (21)
Malawi Mali Mozambique Namibia Niger
Survey Year 2004 2010 2015 2001 2006 2012 2009 2015 2013 2006 2012
Mean 11.64 10.59 9.13 1.72 1.29 1.12 11.13 13.11 14.29 0.69 0.33
S.d. 6.57 4.33 4.68 0.55 0.48 0.32 6.12 6.38 3.61 0.41 0.25
Regions 3 3 3 9 9 6 11 11 13 8 8
(22) (23) (24) (25)
Rwanda Senegal Sierra Leone South Africa
Survey Year 2005 2010 2014 2005 2010 2017 2008 2013 2016
Mean 2.99 2.92 2.87 0.71 0.67 0.47 1.47 1.41 21.25
S.d. 1.33 1.65 1.37 0.59 0.43 0.34 0.79 0.64 5.96
Regions 5 5 5 4 4 4 4 4 9
(26) (27) (28) (29) (30)
Tanzania Togo Uganda Zambia Zimbabwe
Survey Year 2003 2007 2011 2013 2011 2001 2007 2013 2005 2010 2015
Mean 6.85 5.67 5.04 2.40 7.29 15.33 13.85 12.95 18.12 15.29 13.81
S.d. 3.20 3.41 2.50 1.01 2.07 4.94 4.93 3.77 1.75 2.17 2.64
Regions 19 20 20 6 10 9 9 9 10 10 10
Note: In 2012, data are missing for the regions Tombouctou, Gao and Kidal in Mali and are therefore omitted from this last
wave of data. The same applies to Tanzania in 2003 for missing data in Zanzibar.
A.4
Table A.2: Replication of Fortson (2011) Table 4: Consequences of Country Population Selection and Cohort Restriction
Years of School Any Schooling Completed Primary School
(1) (2) (3) (4) (5) (6)
A. Direct Replication of Fortson (2011) – No Cohort Restriction
Regional HIV Prevalencery -0.054** -0.056*** -0.006*** -0.006*** -0.008*** -0.008***
× Post-1980 Cohortc (0.021) (0.021) (0.002) (0.002) (0.002) (0.002)
Ruraliycr -2.705*** -2.729*** -0.195*** -0.198*** -0.276*** -0.278***
(0.272) (0.284) (0.026) (0.027) (0.027) (0.028)
Femaleiycr -1.288*** -1.297*** -0.141*** -0.143*** -0.112*** -0.113***
(0.084) (0.086) (0.018) (0.019) (0.008) (0.008)
Sample
Original Population Survey Year Original Population Survey Year Original Population Survey Year
Weights (2007) Population Weights Weights (2007) Population Weights Weights (2007) Population Weights
Regions 157 157 157 157 157 157
Observations 302,494 302,494 302,494 302,494 302,745 302,745
B. Restricted to BirthYear ≥ 1965
Regional HIV Prevalencery -0.066*** -0.067*** -0.006*** -0.006*** -0.009*** -0.009***
× Post-1980 Cohortc (0.022) (0.022) (0.002) (0.002) (0.002) (0.002)
Ruraliycr -2.717*** -2.744*** -0.196*** -0.199*** -0.282*** -0.285***
(0.288) (0.301) (0.027) (0.028) (0.029) (0.030)
Femaleiycr -1.153*** -1.166*** -0.132*** -0.135*** -0.098*** -0.100***
(0.095) (0.098) (0.019) (0.019) (0.009) (0.009)
Sample
Original Population Survey Year Original Population Survey Year Original Population Survey Year
Weights (2007) Population Weights Weights (2007) Population Weights Weights (2007) Population Weights
Regions 157 157 157 157 157 157
Observations 253,324 253,324 253,324 253,324 253,513 253,513
Note: The dependent variable is described at the top of each column. In columns (1) and (2), it is years of schooling; an indicator for completing any schooling in columns
(3) and (4); and in columns (5) and (6), an indicator for completing primary school. Each regression includes indicators for female and living in a rural area, birth year fixed
effects, and region fixed effects. Regional HIV prevalence is the regional prevalence rate in the survey year in which each individual was observed. Odd numbered columns use
2007 CIA World Factbook population data to adjust DHS weights so that the sum of each country’s weights equals the population; even numbered columns use survey year
WDI population data – as is done in the rest of the paper. All samples include adults between the ages of 15 and 49; restricted to cohorts born in or after 1965, in Panel B.
Standard errors are clustered by region and shown in parentheses.
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Table A.3: Replication of Fortson (2011) Table 6 – Differences Prior to Affected Time Period
A. Dependent Variable: Years of Schooling
(1) (2) (3) (4) (5) (6)
Regional HIV Prevalencery 0.021* -0.003 Regional HIV Prevalencery 0.009 0.013**
× ✶[BirthYear ≥ Placeboc] (0.012) (0.010) × ✶[BirthYear ≥ Placeboc] (0.006) (0.006)
Max. Regional HIV Prevalencer 0.006 0.011*
× ✶[BirthYear ≥ Placeboc] (0.005) (0.005)
Regions 157 157 Regions 289 289 289 289
N 170,542 121,372 N 452,771 452,771 681,018 681,018
B. Dependent Variable: Any Schooling (Years of School > 0)
Regional HIV Prevalencery -0.002** -0.003*** Regional HIV Prevalencery -0.002*** -0.001*
× ✶[BirthYear ≥ Placeboc] (0.001) (0.001) × ✶[BirthYear ≥ Placeboc] (0.001) (0.001)
Max. Regional HIV Prevalencer -0.002*** -0.001**
× ✶[BirthYear ≥ Placeboc] (0.001) (0.001)
Regions 157 157 Regions 289 289 289 289
N 170,542 121,372 N 452,771 452,771 681,018 681,018
C. Dependent Variable: Completed Primary School
Regional HIV Prevalencery 0.001 -0.002*** Regional HIV Prevalencery 0.001 0.002***
× ✶[BirthYear ≥ Placeboc] (0.001) (0.001) × ✶[BirthYear ≥ Placeboc] (0.001) (0.000)
Max. Regional HIV Prevalencer 0.001 0.001**
× ✶[BirthYear ≥ Placeboc] (0.001) (0.000)
Regions 157 157 Regions 289 289 289 289





and survey years and survey years
Placebo Birth Year Cutoff 1970 1970 Placebo Birth Year Cutoff 1970 1970 1975 1975
Cohort restrictions Cohort restrictions
Early ≥ 1965 Early ≥ 1965 ≥ 1965 ≥ 1965 ≥ 1965
Late < 1980 < 1980 Late < 1980 < 1980 < 1980 < 1980
Region FE X X Region FE
Region × Wave FE Region × Wave FE X X X X
Note: The dependent variable is described at the top of each panel. In Panel A, it is years of schooling; an indicator for
completing any schooling in Panel B; and in Panel C, an indicator for completing primary school. Each regression includes
indicators for female and living in a rural area, birth year fixed effects, and the set of region or region by survey wave fixed
effects, as denoted at the bottom of the table. In the expanded sample, a cubic for age is also included. Regional HIV prevalence
is the regional prevalence rate in the survey year in which each individual was observed. Max. regional HIV prevalence is a
time-consistent measure of the highest recorded prevalence rate in the region across all survey years. The sample only includes
pre-1980 cohorts, and observations between the ages of 15 and 49, born in or after 1965; the exact placebo cutoff and cohort
restrictions are denoted in each column. Standard errors are clustered by region and shown in parentheses.
A.6
Table A.4: Effect of HIV on Grade-by-Grade School Completion
At least X Years Completed: 1 2 3 4 5 Primary
(1) (2) (3) (4) (5) (6)
A. Regional HIV Prevalence × Post-1980 Cohort
Regional HIV Prevalencery -0.007*** -0.006*** -0.005*** -0.004*** -0.003** -0.001
× Post-1980 Cohortc (0.001) (0.001) (0.001) (0.001) (0.001) (0.001)
Regions 289 289 289 289 289 289
N 1,320,654 1,320,654 1,320,654 1,320,654 1,320,654 1,323,189
B. Max. Regional HIV Prevalence × Post-1980 Cohort
Max. Regional HIV Prevalencer -0.007*** -0.006*** -0.005*** -0.004*** -0.003*** -0.002**
× Post-1980 Cohortc (0.001) (0.001) (0.001) (0.001) (0.001) (0.001)
Regions 289 289 289 289 289 289
N 1,320,654 1,320,654 1,320,654 1,320,654 1,320,654 1,323,189
C. Regional HIV Prevalence at Age 6
Regional HIV Prevalence -0.006*** -0.005*** -0.005*** -0.004*** -0.004*** -0.003**
at Age 6rc (0.002) (0.002) (0.002) (0.001) (0.001) (0.001)
Regions 254 254 254 254 254 254
N 1,751,328 1,751,328 1,751,328 1,751,328 1,751,328 1,754,126
Note: The dependent variable is described at the top of each column. In columns (1) through (5), it is an indicator equal to
one if at least the stated number of years of schooling were completed. In column (6), the dependent variable is an indicator
equal to one if primary school was completed. Each regression includes a cubic for age, indicators for female and living in
a rural area, birth year fixed effects, and region by survey wave fixed effects. In Panel A, Regional HIV prevalence is the
regional prevalence rate in the survey year in which each individual was observed; in Panel B, HIV prevalence is measured
as a time-consistent measure of the highest record prevalence rate in the region across all survey years; in Panel C, regional
HIV prevalence is a cohort specific estimate of the regional prevalence rate for each cohort’s age six year. All samples include
adults between the ages of 15 and 49; restricted to cohorts born in or after 1965. Standard errors are clustered by region and
shown in parentheses.
Table A.5: Effect of HIV on Education Outcomes - 1987 Treatment Cutoff
Years of School Any Schooling Completed Primary School
(1) (2) (3)
Regional HIV Prevalencery -0.063*** -0.009*** -0.003***
× Post-1987 Cohortc (0.013) (0.002) (0.001)
Clusters 289 289 289
Observations 1,320,654 1,320,654 1,323,189
Note: The dependent variable is described at the top of each column. In column (1), it is years of schooling; an
indicator for completing any schooling in column (2); and in column (3), an indicator for completing primary school.
Each regression includes a cubic for age, indicators for female and living in a rural area, birth year fixed effects, and
region by survey wave fixed effects. Regional HIV prevalence is the regional prevalence rate in the survey year in
which each individual was observed. All samples include adults between the ages of 15 and 49; restricted to cohorts
born in or after 1965. Standard errors are clustered by region and shown in parentheses.
Table A.6: Replication of Fortson (2011) Table 8 –
Effect of HIV on Years Behind Grade for Age: Ages 7 to 14
Full Sample No Orphans Testing Sample No HIV+ Member
(1) (2) (3) (4)
Regional HIV Prevalencery 0.069*** 0.073*** 0.068*** 0.070***
× Post-1992 Cohortc (0.012) (0.013) (0.017) (0.019)
Nonorphans in Nonorphans in HH with
Original countries Nonorphans; original HIV testing sample; no HIV-positive individual;
Sample and survey waves countries and survey original countries original countries
(2001−2005) waves (2001−2005) and survey waves and survey waves
(2001−2005) (2001−2005)
Regions 157 157 139 139
N 163,601 137,799 53,643 49,772
Note: The dependent variable is years behind grade for age. Each regression includes indicators for female and living in a rural
area, birth year fixed effects, and region fixed effects. Regional HIV prevalence is the regional prevalence rate in the survey
year in which each individual was observed. Nonorphan is defined as having both mother and father alive; columns (3) and
(4) include only households within the HIV testing sample. All samples include observations between the ages of 7 and 14.
Standard errors are clustered by region and shown in parentheses.
Table A.7: Replication of Fortson (2011) Table 7 –
Effect of HIV on Education Outcomes - Migration and Mortality (Age < 25)
Years of School Any Schooling Completed Primary School
(1) (2) (3)
A. Original Countries and Survey Waves
Regional HIV Prevalencery -0.038** -0.003** -0.005***
× Post-1980 Cohortc (0.015) (0.001) (0.002)
Clusters 157 157 157
Observations 143,960 143,960 144,017
B. Extended Sample (2001−2017)
Regional HIV Prevalencery -0.042*** -0.003** -0.005***
× Post-1980 Cohortc (0.014) (0.001) (0.002)
Clusters 289 289 289
Observations 650,001 650,001 650,773
Note: The dependent variable is described at the top of each column. In column (1), it is years of schooling; an
indicator for completing any schooling in column (2); and in column (3), an indicator for completing primary school.
In Panel A, the sample and specification are described in Table 7 of Fortson (2011). In Panel B, each regression
includes a cubic for age, indicators for female and living in a rural area, birth year fixed effects, and region by survey
wave fixed effects. Regional HIV prevalence is the regional prevalence rate in the survey year in which each individual
was observed. All samples include adults between the ages of 15 and 25; restricted to cohorts born in or after 1965.
Standard errors are clustered by region and shown in parentheses.
A.8
Table A.8: Effect of HIV on Schooling and Child Labor: Ages 7 to 14
Not Working in
In the Past Seven Days Past Seven Days
Years Behind Work for Pay Work for Years Behind
Grade for Age – Non-Family Family Grade for Age
(1) (2) (3) (4)
Regional HIV Prevalencery 0.052*** -0.002** -0.014*** 0.058***
× Post-1992 Cohortc (0.012) (0.001) (0.002) (0.014)
Mean of Dependent 2.544 0.127 0.274 2.350
Regions 114 114 114 114
N 283,504 263,851 263,028 159,535
Note: The dependent variable in column (1) and (4) is years behind grade for age, in columns (2) and (3) the dependent
variable is an indicator equal to one if doing the work described at the top of the column. Each regression includes a cubic for
age, indicators for female and living in a rural area, birth year fixed effects, and region by survey wave fixed effects. Regional
HIV prevalence is the regional prevalence rate in the survey year in which each individual was observed. Survey waves include:
Burkina Faso (2010); Burundi (2010); Cameroon (2011); Democratic Republic of the Congo (2007); Cote d’Ivoire (2011);
Ethiopia (2011); Gabon (2012); Guinea (2012); Liberia (2007); Malawi (2004); Mali (2001; 2006; 2012); Niger (2006; 2012);
Rwanda (2010); Senegal (2005; 2010); Sierra Leona (2008; 2013). All samples include observations between the ages of 7 and
14. Standard errors are clustered by region and shown in parentheses.
A.9
Table A.9: Replication of Fortson (2011) Table 9: Differences by Sex
A. Dependent Variable: Years of School
(1) (2) (3) (4) (5)
Regional HIV Prevalencery -0.083*** -0.049*** -0.047*** -0.012 -0.007
× Post-1980 Cohortc × Maleiycr (0.014) (0.014) (0.015) (0.010) (0.011)
Regional HIV Prevalencery -0.026 -0.043* -0.035* -0.028*** -0.031***
× Post-1980 Cohortc (0.018) (0.023) (0.019) (0.010) (0.010)
Clusters 157 157 137 289 289
Observations 253,324 253,324 867,584 1,320,654 1,320,654
B. Dependent Variable: Any School (Years of School > 0)
Regional HIV Prevalencery -0.009*** -0.000 0.001 0.002 0.002
× Post-1980 Cohortc × Maleiycr (0.002) (0.002) (0.002) (0.001) (0.001)
Regional HIV Prevalencery -0.001 -0.006* -0.009*** -0.007*** -0.007***
× Post-1980 Cohortc (0.002) (0.003) (0.003) (0.002) (0.002)
Clusters 157 157 137 289 289
Observations 253,324 253,324 867,584 1,320,654 1,320,654
C. Dependent Variable: Completed Primary
Regional HIV Prevalencery -0.009*** -0.008*** -0.007*** -0.002 -0.002
× Post-1980 Cohortc × Maleiycr (0.002) (0.002) (0.002) (0.001) (0.001)
Regional HIV Prevalencery -0.005*** -0.005*** -0.003* -0.000 -0.001
× Post-1980 Cohortc (0.002) (0.002) (0.001) (0.001) (0.001)
Clusters 157 157 137 289 289
Observations 253,513 253,513 868,232 1,323,189 1,323,189
Original Countries Original Countries Original Countries; Expanded Countries Expanded Countries
Sample and survey waves and survey waves expanded survey waves and survey waves and survey waves
(2001 – 2005) (2001 – 2005) (2001 – 2017) (2001 – 2017) (2001 – 2017)
Age (cubic) — — X X X
Rural Indicator X X X X X
HIV Prevalence × Male — X X X —
Post-1980 Cohort × Male — X X X —
Male Indicator X X X X —
Birth Year F.E. X X X X —
Birth Year F.E. × Male — — — — X
Region F.E. X X — — —
Region × Survey Wave F.E. — — X X —
Region × Survey Wave F.E. × Male — — — — X
Note: The dependent variable is described at the top of each panel. In Panel A, it is years of schooling; an indicator for
completing any schooling in Panel B; and in Panel C, an indicator for completing primary school. The set of controls used in
each regression is detailed at the bottom of the table. Regional HIV prevalence is the regional prevalence rate in the survey
year in which each individual was observed. The sample includes all observations between the ages of 15 and 49, born in or
after 1965. Standard errors are clustered by region and shown in parentheses.
A.10
Table A.10: Effect of HIV on Education Outcomes
Men Women
A. Dependent Variable: Years of School
(1) (2) (3) (4) (5) (6)
Regional HIV Prevalencery -0.039*** -0.029***
× Post-1980 Cohortc (0.013) (0.010)
Max. Regional HIV Prevalencer -0.040*** -0.030***
× Post-1980 Cohortc (0.013) (0.010)
Regional HIV Prevalence at Age Sixrc
-0.032** -0.037**
(0.013) (0.017)
Regions 289 289 254 289 289 254
N 619,910 619,910 914,767 700,744 700,744 1,024,316
B. Dependent Variable: Any Schooling (Years of School > 0)
Regional HIV Prevalencery -0.006*** -0.007***
× Post-1980 Cohortc (0.001) (0.001)
Max. Regional HIV Prevalencer -0.006*** -0.007***
× Post-1980 Cohortc (0.001) (0.001)
Regional HIV Prevalence at Age Sixrc
-0.005*** -0.006***
(0.001) (0.002)
Regions 289 289 254 289 289 254
N 619,910 619,910 914,767 700,744 700,744 1,024,316
C. Dependent Variable: Primary Completed
Regional HIV Prevalencery -0.002** -0.000
× Post-1980 Cohortc (0.001) (0.001)
Max. Regional HIV Prevalencer -0.003** -0.001
× Post-1980 Cohortc (0.001) (0.001)
Regional HIV Prevalence at Age Sixrc
-0.003** -0.002
(0.001) (0.001)
Regions 289 289 254 289 289 254
N 620,938 620,938 916,223 702,251 702,251 1,026,027
Note: The dependent variable is described at the top of each panel. In Panel A, it is years of schooling; an indicator for
completing any schooling in Panel B; and in Panel C, an indicator for completing primary school. Each regression includes
a cubic for age, an indicator for living in a rural area, and birth year and region by survey wave fixed effects. Regional
HIV prevalence is the regional prevalence rate in the survey year in which each individual was observed. Max. regional HIV
prevalence is a time-consistent measure of the highest recorded prevalence rate in the region across all survey years, and regional
HIV prevalence at age six is a cohort specific estimate of the regional prevalence rate for each cohort’s age six year. All samples
include adults between the ages of 15 and 49, born in or after 1965. Standard errors are clustered by region and shown in
parentheses.
A.11
Table A.11: Effect of HIV on Education Outcomes – Removing Regions with Highest and Lowest HIV Prevalence
Full Only Include Regions In Following Percentile Range
Sample > 1 > 5 > 10 > 25 < 99 < 95 < 90 < 75 > 1; < 99 > 5; < 95 > 10; < 90 > 25; < 75
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13)
A. Dependent Variable: Years of School
Regional HIV Prevalencery -0.033*** -0.033*** -0.035*** -0.033*** -0.027* -0.037*** -0.041*** -0.035* -0.074** -0.038*** -0.046*** -0.037 -0.077
× Post-1980 Cohortc (0.011) (0.011) (0.011) (0.012) (0.015) (0.011) (0.015) (0.021) (0.037) (0.012) (0.015) (0.024) (0.065)
Regions 289 285 279 268 235 286 271 253 211 282 261 232 157
N 1,320,654 1,308,567 1,271,269 1,195,979 1,010,660 1,304,139 1,252,069 1,170,436 968,849 1,292,052 1,202,684 1,045,761 658,855
B. Dependent Variable: Any Schooling (Years of School > 0)
Regional HIV Prevalencery -0.007*** -0.007*** -0.007*** -0.006*** -0.006*** -0.007*** -0.008*** -0.008*** -0.018*** -0.007*** -0.009*** -0.009*** -0.020***
× Post-1980 Cohortc (0.001) (0.001) (0.001) (0.001) (0.002) (0.001) (0.002) (0.003) (0.004) (0.001) (0.002) (0.003) (0.007)
Regions 289 285 279 268 235 286 271 253 211 282 261 232 157
N 1,320,654 1,308,567 1,271,269 1,195,979 1,010,660 1,304,139 1,252,069 1,170,436 968,849 1,292,052 1,202,684 1,045,761 658,855
C. Dependent Variable: Primary Completed
Regional HIV Prevalencery -0.001 -0.001 -0.001 -0.001 -0.001 -0.002* -0.003** -0.004** -0.012*** -0.002* -0.003** -0.004** -0.015***
× Post-1980 Cohortc (0.001) (0.001) (0.001) (0.001) (0.001) (0.001) (0.001) (0.002) (0.003) (0.001) (0.001) (0.002) (0.005)
Regions 289 285 279 268 235 286 271 253 211 282 261 232 157
N 1,323,189 1,311,096 1,273,737 1,198,322 1,012,846 1,306,673 1,254,441 1,172,537 970,271 1,294,580 1,204,989 1,047,670 659,928
Note: The dependent variable is described at the top of each panel. In Panel A, it is years of schooling; an indicator for completing any schooling in Panel B; and in Panel
C, an indicator for completing primary school. Each regression includes indicators for female and living in a rural area, birth year fixed effects, and wave specific region fixed
effects. Regional HIV prevalence is the regional prevalence rate in the survey year in which each individual was observed. All samples include adults between the ages of 15
and 49, born in or after 1965. Standard errors are clustered by region and shown in parentheses.
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